Loading Events

How Vaccines and Screening Can Prevent Cervical Cancer

January 26 @ 12:00 pm - 12:45 pm EST

In the United States, there are more than 100 diagnostic tests and procedures available for detecting diseases and monitoring their progression. Diagnostic tools are also used to guide treatments and evaluate their effectiveness. Some tests are invasive, such as a biopsy or endoscopy; whereas others are noninvasive, such as x-rays and ultrasound imaging procedures.

Innovations in diagnostics provide access to health information, helping women make informed decisions about their health care at every stage of their lives. Screening and diagnostic testing can lead to earlier detection of disease, improve health outcomes, and contribute toward reducing health disparities among women.

SWHR is hosting a series of public forums to share educational information about the importance and value of innovative diagnostics throughout the lifespan and across disease states and conditions. The events will discuss how to improve health outcomes for diseases and conditions that disproportionately or exclusively affect women, with special a focus on cancers, reproductive health, and bone health.

 

The SWHR Value of Diagnostics within Women’s Health series includes:

  • How Vaccines and Screening Can Prevent Cervical Cancer (January 26, 2022)
  • Improving Lives by Detecting Sexually Transmitted Infections Early (April)
  • Assessing and Promoting Bone Health Across the Lifespan (May)
  • How Hormones Can Tell a Fertility Story (June)
  • Ovarian Cancer Screening: More than a Pelvic Exam (September)
  • Understanding the Tests that Could Save My Breasts (October) 

REGISTER

Details

Date:
January 26
Time:
12:00 pm - 12:45 pm EST
Event Category:
Website:
https://swhr-org.zoom.us/webinar/register/WN_iSSwJiTsRoi0in5RQncDZA

Organizer

SWHR

Goals

  • Discuss the impacts of cervical cancer on women’s health, including disparities in disease burden and access to care
  • Provide an overview of screening guidelines and diagnostic tests for patients and key considerations for disease management
  • Emphasize ways to empower women and improve quality of care and general wellbeing

Panelists

Carolina Aristizabal, MD, MPH, CHES
Manager, Office of Community Outreach & Engagement, Norris Comprehensive Cancer Center, University of Southern California
Carolina Aristizabal, MD, MPH, CHES
Manager, Office of Community Outreach & Engagement, Norris Comprehensive Cancer Center, University of Southern California

Dr. Aristizabal is an occupational health physician with a master’s in public health and a certified community health educator specialist. She has experience for over 14 years working with underrepresented minorities from Latin American countries suffering from cancer and other chronic diseases. She is also a cancer researcher focused on reducing cancer health disparities among underserved populations. Dr. Aristizabal currently works as the manager for the Office of Community Outreach and Engagement at the USC Norris Comprehensive Cancer Center.

La Dra. Aristizábal es médico especialista en salud ocupacional, con una maestría en salud pública y es especialista certificada en educación en salud comunitaria. Tiene experiencia de más de 14 años trabajando con minorías subrepresentadas de países Latinoamericanos que padecen cáncer y otras enfermedades crónicas. También es investigadora del cáncer centrada en reducir las disparidades en la salud del cáncer entre las poblaciones desatendidas. La Dra. Aristizábal trabaja actualmente como gerente de la oficina de extensión y participación comunitaria en el Centro Integral de Cáncer Norris de la USC.

Aristizabal

Debbie Saslow, PhD
Managing Director, HPV & GYN Cancers, American Cancer Society
Debbie Saslow, PhD
Managing Director, HPV & GYN Cancers, American Cancer Society

Debbie Saslow, PhD, is the Director of Cancer Control Intervention for HPV Vaccination and Women’s Cancers at the American Cancer Society where she has worked for 20 years. Dr. Saslow is responsible for developing and updating ACS guidelines, including guidelines for breast and cervical cancer screening and for HPV vaccination. She serves as the Society’s lead for HPV-related cancers and directs their HPV vaccination nationwide priority program of work, provides strategic direction and leads staff teams working on the implementation of HPV-related activities, and provides evidence-based guidelines to the Society. Dr. Saslow is also the Principal Investigator on two cooperative agreements to increase HPV vaccination, and serves as the Vice-Chair of the National HPV Vaccination Roundtable. Before joining the Society, Dr. Saslow was coordinator of the President’s National Action Plan on Breast Cancer. She received her undergraduate degree in biology with honors from Brown University, her PhD in human and molecular genetics from Yale University, and completed a postdoctoral fellowship at the National Cancer Institutes’ Laboratory of Pathology in Women’s Cancers.

Sponsor

SWHR’s Value of Diagnostics within Women’s Health series is supported by an educational sponsorship from Roche. SWHR maintains editorial control and independence over educational content.